Effect of polymorphisms in drug metabolism and transportation on plasma concentration of atorvastatin and its metabolites in patients with chronic kidney disease

Dyslipidemia due to renal insufficiency is a common complication in patients with chronic kidney diseases (CKD), and a major risk factor for the development of cardiovascular events. Atorvastatin (AT) is mainly used in the treatment of dyslipidemia in patients with CKD. However, response to the ator...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Zebin, Wu, Zemin, Liu, Ruixue, Du, Qin, Fu, Xian, Li, Min, Kuang, Yongjun, Lin, Shen, Wu, Jiaxuan, Xie, Weiji, Shi, Ganggang, Peng, Yanqiang, Zheng, Fuchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010391/
https://www.ncbi.nlm.nih.gov/pubmed/36923356
http://dx.doi.org/10.3389/fphar.2023.1102810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010391/
https://www.ncbi.nlm.nih.gov/pubmed/36923356
http://dx.doi.org/10.3389/fphar.2023.1102810

Ejemplares similares